{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:04:44Z","timestamp":1786982684200,"version":"build-2736575974"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The research was carried out at the expense of the subsidy for the implementation of the state task","award":["FGMF-2025-0003"],"award-info":[{"award-number":["FGMF-2025-0003"]}]},{"name":"The research was carried out at the expense of the subsidy for the implementation of the state task","award":["FGMF-2025-0003"],"award-info":[{"award-number":["FGMF-2025-0003"]}]},{"name":"The research was carried out at the expense of the subsidy for the implementation of the state task","award":["FGMF-2025-0003"],"award-info":[{"award-number":["FGMF-2025-0003"]}]},{"name":"The research was carried out at the expense of the subsidy for the implementation of the state task","award":["FGMF-2025-0003"],"award-info":[{"award-number":["FGMF-2025-0003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Nutr Rep"],"DOI":"10.1007\/s13668-025-00679-4","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T07:00:31Z","timestamp":1751094031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Probiotics and Prebiotics in Post-Myocardial Infarction Rehabilitation: Mechanisms, Benefits, and Future Directions"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5632-7040","authenticated-orcid":false,"given":"Georgy","family":"Leonov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5670-9607","authenticated-orcid":false,"given":"Elena","family":"Livantsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5274-2773","authenticated-orcid":false,"given":"Yurgita","family":"Varaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9262-9233","authenticated-orcid":false,"given":"Antonina","family":"Starodubova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"key":"679_CR1","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.jacc.2022.11.001","volume":"80","author":"M Lindstrom","year":"2022","unstructured":"Lindstrom M, DeCleene N, Dorsey H, Fuster V, Johnson CO, LeGrand KE, Mensah GA, Razo C, Stark B, Varieur Turco J, et al. Global burden of cardiovascular diseases and risks collaboration, 1990\u20132021. J Am Coll Cardiol. 2022;80:2372\u2013425. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.001.","journal-title":"J Am Coll Cardiol"},{"key":"679_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12872-023-03231-w","volume":"23","author":"N Salari","year":"2023","unstructured":"Salari N, Morddarvanjoghi F, Abdolmaleki A, Rasoulpoor S, Khaleghi AA, Hezarkhani LA, Shohaimi S, Mohammadi M. The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2023;23:206. https:\/\/doi.org\/10.1186\/s12872-023-03231-w.","journal-title":"BMC Cardiovasc Disord"},{"key":"679_CR3","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","volume":"114","author":"JF Bentzon","year":"2014","unstructured":"Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114:1852\u201366. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.302721.","journal-title":"Circ Res"},{"key":"679_CR4","doi-asserted-by":"publisher","unstructured":"Antza C, Gallo A, Boutari C, Ershova A, Gurses KM, Lewek J, Mirmaksudov M, Silbernagel G, Sandstedt J, Lebedeva A. Prevention of cardiovascular disease in young adults: Focus on gender differences. A collaborative review from the EAS Young Fellows. Atherosclerosis. 2023;384:117272. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117272.","DOI":"10.1016\/j.atherosclerosis.2023.117272"},{"key":"679_CR5","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3390\/biomedicines12071601","volume":"12","author":"EN Livantsova","year":"2024","unstructured":"Livantsova EN, Leonov GE, Starodubova AV, Varaeva YR, Vatlin AA, Koshechkin SI, Korotkova TN, Nikityuk DB. Diet and the gut microbiome as determinants modulating metabolic outcomes in young obese adults. Biomedicines. 2024;12:1601. https:\/\/doi.org\/10.3390\/biomedicines12071601.","journal-title":"Biomedicines"},{"key":"679_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12902-019-0463-3","volume":"20","author":"I Kyrou","year":"2020","unstructured":"Kyrou I, Tsigos C, Mavrogianni C, Cardon G, Van Stappen V, Latomme J, Kivel\u00e4 J, Wikstr\u00f6m K, Tsochev K, Nanasi A, et al. Sociodemographic and lifestyle-related risk factors for identifying vulnerable groups for type 2 diabetes: a narrative review with emphasis on data from Europe. BMC Endocr Disord. 2020;20:134. https:\/\/doi.org\/10.1186\/s12902-019-0463-3.","journal-title":"BMC Endocr Disord"},{"key":"679_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.mayocpiqo.2023.11.005","volume":"8","author":"A Pikula","year":"2024","unstructured":"Pikula A, Gulati M, Bonnet JP, Ibrahim S, Chamoun S, Freeman AM, Reddy K. Promise of lifestyle medicine for heart disease, diabetes mellitus, and cerebrovascular diseases. Mayo Clin Proc Innov Qual Outcomes. 2024;8:151\u201365. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2023.11.005.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"679_CR8","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1161\/CIR.0000000000001289","volume":"150","author":"TM Brown","year":"2024","unstructured":"Brown TM, Pack QR, Aberegg E, Brewer LC, Ford YR, Forman DE, Gathright EC, Khadanga S, Ozemek C, Thomas RJ, et al. Core components of cardiac rehabilitation programs: 2024 Update: A scientific statement from the American heart association and the American association of cardiovascular and pulmonary rehabilitation. Circulation. 2024;150:e328\u201347. https:\/\/doi.org\/10.1161\/CIR.0000000000001289.","journal-title":"Circulation"},{"key":"679_CR9","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/biomedicines10050948","volume":"10","author":"PD Papadopoulos","year":"2022","unstructured":"Papadopoulos PD, Tsigalou C, Valsamaki PN, Konstantinidis TG, Voidarou C, Bezirtzoglou E. The emerging role of the gut microbiome in cardiovascular disease: Current knowledge and perspectives. Biomedicines. 2022;10:948. https:\/\/doi.org\/10.3390\/biomedicines10050948.","journal-title":"Biomedicines"},{"key":"679_CR10","doi-asserted-by":"publisher","first-page":"e0180717","DOI":"10.1371\/journal.pone.0180717","volume":"12","author":"Z-X Wu","year":"2017","unstructured":"Wu Z-X, Li S-F, Chen H, Song J-X, Gao Y-F, Zhang F, Cao C-F. The changes of gut microbiota after acute myocardial infarction in rats. PLoS ONE. 2017;12:e0180717. https:\/\/doi.org\/10.1371\/journal.pone.0180717.","journal-title":"PLoS ONE"},{"key":"679_CR11","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1038\/s41467-023-43167-5","volume":"14","author":"H-C Chen","year":"2023","unstructured":"Chen H-C, Liu Y-W, Chang K-C, Wu Y-W, Chen Y-M, Chao Y-K, You M-Y, Lundy DJ, Lin C-J, Hsieh ML, et al. Gut butyrate-producers confer post-infarction cardiac protection. Nat Commun. 2023;14:7249. https:\/\/doi.org\/10.1038\/s41467-023-43167-5.","journal-title":"Nat Commun"},{"key":"679_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40168-022-01271-6","volume":"10","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Deng J, Pan X, Meng D, Zhu Y, Bai Y, Shi C, Duan Y, Wang T, Li X, et al. Gut microbiome mediates the protective effects of exercise after myocardial infarction. Microbiome. 2022;10:82. https:\/\/doi.org\/10.1186\/s40168-022-01271-6.","journal-title":"Microbiome"},{"key":"679_CR13","doi-asserted-by":"publisher","first-page":"5575245","DOI":"10.1155\/2021\/5575245","volume":"2021","author":"H Anwar","year":"2021","unstructured":"Anwar H, Iftikhar A, Muzaffar H, Almatroudi A, Allemailem KS, Navaid S, Saleem S, Khurshid M. Biodiversity of gut microbiota: Impact of various host and environmental factors. BioMed Res Int. 2021;2021:5575245. https:\/\/doi.org\/10.1155\/2021\/5575245.","journal-title":"BioMed Res Int"},{"key":"679_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, Mele MC. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7:14. https:\/\/doi.org\/10.3390\/microorganisms7010014.","journal-title":"Microorganisms"},{"key":"679_CR15","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.14336\/AD.2022.0104","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C. Functions of gut microbiota metabolites, current status and future perspectives. Aging Dis. 2022;13:1106. https:\/\/doi.org\/10.14336\/AD.2022.0104.","journal-title":"Aging Dis"},{"key":"679_CR16","doi-asserted-by":"publisher","first-page":"114985","DOI":"10.1016\/j.biopha.2023.114985","volume":"164","author":"M Zhao","year":"2023","unstructured":"Zhao M, Chu J, Feng S, Guo C, Xue B, He K, Li L. Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review. Biomed Pharmacother Biomedecine Pharmacother. 2023;164:114985. https:\/\/doi.org\/10.1016\/j.biopha.2023.114985.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"679_CR17","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54:2325\u201340. https:\/\/doi.org\/10.1194\/jlr.R036012.","journal-title":"J Lipid Res"},{"key":"679_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.trsl.2016.07.007","volume":"179","author":"WHW Tang","year":"2017","unstructured":"Tang WHW, Hazen SL. Microbiome, trimethylamine N-Oxide (TMAO), and cardiometabolic disease. Transl Res J Lab Clin Med. 2017;179:108\u201315. https:\/\/doi.org\/10.1016\/j.trsl.2016.07.007.","journal-title":"Transl Res J Lab Clin Med"},{"key":"679_CR19","doi-asserted-by":"publisher","first-page":"114295","DOI":"10.1016\/j.biopha.2023.114295","volume":"160","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen R, Zhang D, Qi S, Liu Y. Metabolite interactions between host and microbiota during health and disease: Which feeds the other? Biomed Pharmacother Biomedecine Pharmacother. 2023;160:114295. https:\/\/doi.org\/10.1016\/j.biopha.2023.114295.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"679_CR20","doi-asserted-by":"publisher","unstructured":"Amenyogbe E, Droepenu EK, Ayisi CL, Boamah GA, Duker RQ, Abarike ED, Huang J. Impact of probiotics, prebiotics, and synbiotics on digestive enzymes, oxidative stress, and antioxidant defense in fish farming: current insights and future perspectives. Front Mar Sci. 2024;11: https:\/\/doi.org\/10.3389\/fmars.2024.1368436.","DOI":"10.3389\/fmars.2024.1368436"},{"key":"679_CR21","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.3390\/foods10123075","volume":"10","author":"V Cella","year":"2021","unstructured":"Cella V, Bimonte VM, Sabato C, Paoli A, Baldari C, Campanella M, Lenzi A, Ferretti E, Migliaccio S. Nutrition and physical activity-induced changes in gut microbiota: Possible implications for human health and athletic performance. Foods. 2021;10:3075. https:\/\/doi.org\/10.3390\/foods10123075.","journal-title":"Foods"},{"key":"679_CR22","doi-asserted-by":"publisher","first-page":"205031212412574","DOI":"10.1177\/20503121241257486","volume":"12","author":"Z Sahle","year":"2024","unstructured":"Sahle Z, Engidaye G, Shenkute Gebreyes D, Adenew B, Abebe TA. Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond. SAGE Open Med. 2024;12:20503121241257490. https:\/\/doi.org\/10.1177\/20503121241257486.","journal-title":"SAGE Open Med"},{"key":"679_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11906-020-01080-y","volume":"22","author":"A Dixon","year":"2020","unstructured":"Dixon A, Robertson K, Yung A, Que M, Randall H, Wellalagodage D, Cox T, Robertson D, Chi C, Sun J. Efficacy of probiotics in patients of cardiovascular disease risk: a systematic review and meta-analysis. Curr Hypertens Rep. 2020;22:74. https:\/\/doi.org\/10.1007\/s11906-020-01080-y.","journal-title":"Curr Hypertens Rep"},{"key":"679_CR24","doi-asserted-by":"publisher","first-page":"1154888","DOI":"10.3389\/fcvm.2023.1154888","volume":"10","author":"Y Lei","year":"2023","unstructured":"Lei Y, Xu M, Huang N, Yuan Z. Meta-analysis of the effect of probiotics or synbiotics on the risk factors in patients with coronary artery disease. Front Cardiovasc Med. 2023;10:1154888. https:\/\/doi.org\/10.3389\/fcvm.2023.1154888.","journal-title":"Front Cardiovasc Med"},{"key":"679_CR25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41371-022-00698-6","volume":"36","author":"SK Masenga","year":"2022","unstructured":"Masenga SK, Hamooya B, Hangoma J, Hayumbu V, Ertuglu LA, Ishimwe J, Rahman S, Saleem M, Laffer CL, Elijovich F, et al. Recent advances in modulation of cardiovascular diseases by the gut microbiota. J Hum Hypertens. 2022;36:952\u20139. https:\/\/doi.org\/10.1038\/s41371-022-00698-6.","journal-title":"J Hum Hypertens"},{"key":"679_CR26","doi-asserted-by":"publisher","unstructured":"Jaimez-Alvarado S, L\u00f3pez-Tenorio II, Barrag\u00e1n-De los Santos J, Bello-Vega DC, G\u00f3mez FJR, Amedei A, Berrios-B\u00e1rcenas EA, Aguirre-Garc\u00eda MM. Gut-Heart axis: Microbiome involvement in restrictive cardiomyopathies. Biomedicines. 2025;13:144. https:\/\/doi.org\/10.3390\/biomedicines13010144.","DOI":"10.3390\/biomedicines13010144"},{"key":"679_CR27","doi-asserted-by":"publisher","unstructured":"Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Inflammatory and microbiota-related regulation of the intestinal epithelial barrier. Front Nutr. 2021;8: https:\/\/doi.org\/10.3389\/fnut.2021.718356.","DOI":"10.3389\/fnut.2021.718356"},{"key":"679_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med. 2024;19:275\u201393. https:\/\/doi.org\/10.1007\/s11739-023-03374-w.","journal-title":"Intern Emerg Med"},{"key":"679_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13054-025-05309-7","volume":"29","author":"DE Soranno","year":"2025","unstructured":"Soranno DE, Coopersmith CM, Brinkworth JF, Factora FNF, Muntean JH, Mythen MG, Raphael J, Shaw AD, Vachharajani V, Messer JS. A review of gut failure as a cause and consequence of critical illness. Crit Care. 2025;29:91. https:\/\/doi.org\/10.1186\/s13054-025-05309-7.","journal-title":"Crit Care"},{"key":"679_CR30","doi-asserted-by":"publisher","unstructured":"Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure. Int J Cardiol. 2012;157:80\u201385. https:\/\/doi.org\/10.1016\/j.ijcard.2010.12.016.","DOI":"10.1016\/j.ijcard.2010.12.016"},{"key":"679_CR31","doi-asserted-by":"publisher","unstructured":"Huo J-Y, Jiang W-Y, Yin T, Xu H, Lyu Y-T, Chen Y-Y, Chen M, Geng J, Jiang Z-X, Shan Q-J. Intestinal Barrier Dysfunction Exacerbates Neuroinflammation via the TLR4 Pathway in Mice With Heart Failure. Front Physiol. 2021;12: https:\/\/doi.org\/10.3389\/fphys.2021.712338.","DOI":"10.3389\/fphys.2021.712338"},{"key":"679_CR32","doi-asserted-by":"publisher","first-page":"121150","DOI":"10.1016\/j.lfs.2022.121150","volume":"311","author":"F Ahmad","year":"2022","unstructured":"Ahmad F, Karim A, Khan J, Qaisar R. Plasma zonulin correlates with cardiac dysfunction and poor physical performance in patients with chronic heart failure. Life Sci. 2022;311:121150. https:\/\/doi.org\/10.1016\/j.lfs.2022.121150.","journal-title":"Life Sci"},{"key":"679_CR33","doi-asserted-by":"publisher","unstructured":"Nendl A, Andersen G\u00d8, Seljeflot I, Tr\u00f8seid M, Awoyemi A. Intestinal fatty acid binding protein is associated with infarct size and cardiac function in acute heart failure following myocardial infarction. Open Heart. 2024;11: https:\/\/doi.org\/10.1136\/openhrt-2024-002868.","DOI":"10.1136\/openhrt-2024-002868"},{"key":"679_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.amjms.2024.07.004","volume":"368","author":"I Oikonomou","year":"2024","unstructured":"Oikonomou I, Papageorgiou A, de Lastic A-L, Moulias A, Georgopoulou G-A, Mouzaki A, Koufou E-E, Tsigkas G, Gogos C, Davlouros P, et al. Gut barrier dysfunction, endotoxemia and inflammatory response in STEMI patients and effect of primary PCI. Am J Med Sci. 2024;368:485\u201393. https:\/\/doi.org\/10.1016\/j.amjms.2024.07.004.","journal-title":"Am J Med Sci"},{"key":"679_CR35","doi-asserted-by":"publisher","first-page":"12465","DOI":"10.3390\/ijms252212465","volume":"25","author":"K Rivera","year":"2024","unstructured":"Rivera K, Gonzalez L, Bravo L, Manjarres L, Andia ME. The gut-heart axis: Molecular perspectives and implications for myocardial infarction. Int J Mol Sci. 2024;25:12465. https:\/\/doi.org\/10.3390\/ijms252212465.","journal-title":"Int J Mol Sci"},{"key":"679_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/cvr\/cvab114","volume":"118","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang S, Li B, Luo Y, Gong Y, Jin X, Zhang J, Zhou Y, Zhuo X, Wang Z, et al. Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome. Cardiovasc Res. 2022;118:785\u201397. https:\/\/doi.org\/10.1093\/cvr\/cvab114.","journal-title":"Cardiovasc Res"},{"key":"679_CR37","doi-asserted-by":"publisher","first-page":"10496","DOI":"10.1038\/s41598-018-28777-0","volume":"8","author":"PM Grin","year":"2018","unstructured":"Grin PM, Dwivedi DJ, Chathely KM, Trigatti BL, Prat A, Seidah NG, Liaw PC, Fox-Robichaud AE. Low-density lipoprotein (LDL)-dependent uptake of Gram-positive lipoteichoic acid and Gram-negative lipopolysaccharide occurs through LDL receptor. Sci Rep. 2018;8:10496. https:\/\/doi.org\/10.1038\/s41598-018-28777-0.","journal-title":"Sci Rep"},{"key":"679_CR38","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/biom10040598","volume":"10","author":"O Meilhac","year":"2020","unstructured":"Meilhac O, Tanaka S, Couret D. High-Density Lipoproteins Are Bug Scavengers. Biomolecules. 2020;10:598. https:\/\/doi.org\/10.3390\/biom10040598.","journal-title":"Biomolecules"},{"key":"679_CR39","doi-asserted-by":"publisher","unstructured":"Rong S, Li B, Chen L, Sun Y, Du Y, Liu B, Robinson JG, Bao W. Association of low\u2010density lipoprotein cholesterol levels with more than 20\u2010year risk of cardiovascular and all\u2010cause mortality in the general population. J Am Heart Assoc. 2022.https:\/\/doi.org\/10.1161\/JAHA.121.023690.","DOI":"10.1161\/JAHA.121.023690"},{"key":"679_CR40","doi-asserted-by":"publisher","unstructured":"Nogal A, Louca P, Zhang X, Wells PM, Steves CJ, Spector TD, Falchi M, Valdes AM, Menni C. Circulating Levels of the Short-Chain Fatty Acid Acetate Mediate the Effect of the Gut Microbiome on Visceral Fat. Front Microbiol. 2021;12: https:\/\/doi.org\/10.3389\/fmicb.2021.711359.","DOI":"10.3389\/fmicb.2021.711359"},{"key":"679_CR41","doi-asserted-by":"publisher","first-page":"115005","DOI":"10.1016\/j.biopha.2023.115005","volume":"165","author":"SE Elkholy","year":"2023","unstructured":"Elkholy SE, Maher SA, Abd El-Hamid NR, Elsayed HA, Hassan WA, Abdelmaogood AKK, Hussein SM, Jaremko M, Alshawwa SZ, Alharbi HM, et al. The immunomodulatory effects of probiotics and azithromycin in dextran sodium sulfate-induced ulcerative colitis in rats via TLR4-NF-\u03baB and p38-MAPK pathway. Biomed Pharmacother Biomedecine Pharmacother. 2023;165:115005. https:\/\/doi.org\/10.1016\/j.biopha.2023.115005.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"679_CR42","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/nu15092211","volume":"15","author":"W Fusco","year":"2023","unstructured":"Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, Lener E, Mele MC, Gasbarrini A, Collado MC, et al. Short-chain fatty-acid-producing bacteria: Key components of the human gut microbiota. Nutrients. 2023;15:2211. https:\/\/doi.org\/10.3390\/nu15092211.","journal-title":"Nutrients"},{"key":"679_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/cphy.c170014","volume":"8","author":"S Sivaprakasam","year":"2017","unstructured":"Sivaprakasam S, Bhutia YD, Yang S, Ganapathy V. Short-chain fatty acid transporters: Role in colonic homeostasis. Compr Physiol. 2017;8:299\u2013314. https:\/\/doi.org\/10.1002\/cphy.c170014.","journal-title":"Compr Physiol"},{"key":"679_CR44","doi-asserted-by":"publisher","first-page":"1158200","DOI":"10.3389\/fimmu.2023.1158200","volume":"14","author":"Y Dong","year":"2023","unstructured":"Dong Y, Zhang K, Wei J, Ding Y, Wang X, Hou H, Wu J, Liu T, Wang B, Cao H. Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy? Front Immunol. 2023;14:1158200. https:\/\/doi.org\/10.3389\/fimmu.2023.1158200.","journal-title":"Front Immunol"},{"key":"679_CR45","doi-asserted-by":"publisher","unstructured":"Lu Y, Zhang Y, Zhao X, Shang C, Xiang M, Li L, Cui X. Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease. Front Cardiovasc Med. 2022;9: https:\/\/doi.org\/10.3389\/fcvm.2022.900381.","DOI":"10.3389\/fcvm.2022.900381"},{"key":"679_CR46","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.119.043081","volume":"141","author":"DM Kaye","year":"2020","unstructured":"Kaye DM, Shihata WA, Jama HA, Tsyganov K, Ziemann M, Kiriazis H, Horlock D, Vijay A, Giam B, Vinh A, et al. Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease. Circulation. 2020;141:1393\u2013403. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.043081.","journal-title":"Circulation"},{"key":"679_CR47","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/nu3100858","volume":"3","author":"MAR Vinolo","year":"2011","unstructured":"Vinolo MAR, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients. 2011;3:858\u201376. https:\/\/doi.org\/10.3390\/nu3100858.","journal-title":"Nutrients"},{"key":"679_CR48","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3390\/jpm12111805","volume":"12","author":"M Yukino-Iwashita","year":"2022","unstructured":"Yukino-Iwashita M, Nagatomo Y, Kawai A, Taruoka A, Yumita Y, Kagami K, Yasuda R, Toya T, Ikegami Y, Masaki N, et al. Short-chain fatty acids in gut-heart axis: Their role in the pathology of heart failure. J Pers Med. 2022;12:1805. https:\/\/doi.org\/10.3390\/jpm12111805.","journal-title":"J Pers Med"},{"key":"679_CR49","doi-asserted-by":"publisher","first-page":"27062","DOI":"10.1038\/s41598-024-78463-7","volume":"14","author":"J Zhou","year":"2024","unstructured":"Zhou J, Zhang H, Huo P, Shen H, Huang Q, Yang L, Liu A, Chen G, Tao F, Liu K, et al. The association between circulating short-chain fatty acids and blood pressure in Chinese elderly population. Sci Rep. 2024;14:27062. https:\/\/doi.org\/10.1038\/s41598-024-78463-7.","journal-title":"Sci Rep"},{"key":"679_CR50","doi-asserted-by":"publisher","first-page":"e0282685","DOI":"10.1371\/journal.pone.0282685","volume":"18","author":"H Ma","year":"2023","unstructured":"Ma H, Yang L, Liu Y, Yan R, Wang R, Zhang P, Bai Z, Liu Y, Ren Y, Li Y, et al. Butyrate suppresses atherosclerotic inflammation by regulating macrophages and polarization via GPR43\/HDAC-miRNAs axis in ApoE\u2212\/\u2212 mice. PLoS ONE. 2023;18:e0282685. https:\/\/doi.org\/10.1371\/journal.pone.0282685.","journal-title":"PLoS ONE"},{"key":"679_CR51","doi-asserted-by":"publisher","first-page":"107096","DOI":"10.1016\/j.vph.2022.107096","volume":"146","author":"H Zhong","year":"2022","unstructured":"Zhong H, Yu H, Chen J, Mok SWF, Tan X, Zhao B, He S, Lan L, Fu X, Chen G, et al. The short-chain fatty acid butyrate accelerates vascular calcification via regulation of histone deacetylases and NF-\u03baB signaling. Vascul Pharmacol. 2022;146:107096. https:\/\/doi.org\/10.1016\/j.vph.2022.107096.","journal-title":"Vascul Pharmacol"},{"key":"679_CR52","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s12265-022-10330-0","volume":"16","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zhang H, Fan X, Wang J, Yin Y, Zhang Y, Shi K, Yu F. The role of gut microbiota and trimethylamine N-oxide in cardiovascular diseases. J Cardiovasc Transl Res. 2023;16:581\u20139. https:\/\/doi.org\/10.1007\/s12265-022-10330-0.","journal-title":"J Cardiovasc Transl Res"},{"key":"679_CR53","doi-asserted-by":"publisher","first-page":"1085041","DOI":"10.3389\/fendo.2023.1085041","volume":"14","author":"J Zhen","year":"2023","unstructured":"Zhen J, Zhou Z, He M, Han H-X, Lv E-H, Wen P-B, Liu X, Wang Y-T, Cai X-C, Tian J-Q, et al. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases. Front Endocrinol. 2023;14:1085041. https:\/\/doi.org\/10.3389\/fendo.2023.1085041.","journal-title":"Front Endocrinol"},{"key":"679_CR54","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s12012-021-09656-z","volume":"21","author":"S He","year":"2021","unstructured":"He S, Jiang H, Zhuo C, Jiang W. Trimethylamine\/Trimethylamine-N-Oxide as a key between diet and cardiovascular diseases. Cardiovasc Toxicol. 2021;21:593\u2013604. https:\/\/doi.org\/10.1007\/s12012-021-09656-z.","journal-title":"Cardiovasc Toxicol"},{"key":"679_CR55","doi-asserted-by":"publisher","first-page":"7154","DOI":"10.3390\/ijms23137154","volume":"23","author":"S Maffei","year":"2022","unstructured":"Maffei S, Forini F, Canale P, Nicolini G, Guiducci L. Gut microbiota and sex hormones: Crosstalking players in cardiometabolic and cardiovascular disease. Int J Mol Sci. 2022;23:7154. https:\/\/doi.org\/10.3390\/ijms23137154.","journal-title":"Int J Mol Sci"},{"key":"679_CR56","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/ph16040504","volume":"16","author":"M Shanmugham","year":"2023","unstructured":"Shanmugham M, Bellanger S, Leo CH. Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in cardio-metabolic diseases: Detection, mechanism, and potential therapeutics. Pharmaceuticals. 2023;16:504. https:\/\/doi.org\/10.3390\/ph16040504.","journal-title":"Pharmaceuticals"},{"key":"679_CR57","doi-asserted-by":"publisher","first-page":"12511","DOI":"10.3390\/ijms252312511","volume":"25","author":"K Jaworska","year":"2024","unstructured":"Jaworska K, Kopacz W, Koper M, Ufnal M. Microbiome-Derived Trimethylamine N-Oxide (TMAO) as a multifaceted biomarker in cardiovascular disease: Challenges and opportunities. Int J Mol Sci. 2024;25:12511. https:\/\/doi.org\/10.3390\/ijms252312511.","journal-title":"Int J Mol Sci"},{"key":"679_CR58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.toxlet.2016.12.017","volume":"267","author":"M Makrecka-Kuka","year":"2017","unstructured":"Makrecka-Kuka M, Volska K, Antone U, Vilskersts R, Grinberga S, Bandere D, Liepinsh E, Dambrova M. Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria. Toxicol Lett. 2017;267:32\u20138. https:\/\/doi.org\/10.1016\/j.toxlet.2016.12.017.","journal-title":"Toxicol Lett"},{"key":"679_CR59","doi-asserted-by":"publisher","first-page":"100554","DOI":"10.1016\/j.ijcha.2020.100554","volume":"29","author":"P B\u00fcttner","year":"2020","unstructured":"B\u00fcttner P, Okun JG, Hauke J, Holzwirth E, Obradovic D, Hindricks G, Thiele H, Kornej J. Trimethylamine N-oxide in atrial fibrillation progression. Int J Cardiol Heart Vasc. 2020;29:100554. https:\/\/doi.org\/10.1016\/j.ijcha.2020.100554.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"679_CR60","doi-asserted-by":"publisher","first-page":"922441","DOI":"10.3389\/fcvm.2022.922441","volume":"9","author":"H Wang","year":"2022","unstructured":"Wang H, Luo Q, Ding X, Chen L, Zhang Z. Trimethylamine N-oxide and its precursors in relation to blood pressure: A mendelian randomization study. Front Cardiovasc Med. 2022;9:922441. https:\/\/doi.org\/10.3389\/fcvm.2022.922441.","journal-title":"Front Cardiovasc Med"},{"key":"679_CR61","doi-asserted-by":"publisher","unstructured":"Guo S, Bai H, Han Y, Wu Y, Peng R, Zhang X, Liang B, Zhao Q, Ma M, Zhang P, et al. Association of the gut microbe-dependent trimethylamine N-oxide and its precursors with risk of hypertension: a cross-sectional study in rural northeastern China. Nutr Metab Cardiovasc Dis. 2025;0: https:\/\/doi.org\/10.1016\/j.numecd.2025.104032.","DOI":"10.1016\/j.numecd.2025.104032"},{"key":"679_CR62","doi-asserted-by":"publisher","first-page":"102115","DOI":"10.1016\/j.redox.2021.102115","volume":"46","author":"S Jiang","year":"2021","unstructured":"Jiang S, Shui Y, Cui Y, Tang C, Wang X, Qiu X, Hu W, Fei L, Li Y, Zhang S, et al. Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II\u2013induced hypertension. Redox Biol. 2021;46:102115. https:\/\/doi.org\/10.1016\/j.redox.2021.102115.","journal-title":"Redox Biol"},{"key":"679_CR63","doi-asserted-by":"publisher","first-page":"109271","DOI":"10.1016\/j.mehy.2019.109271","volume":"130","author":"M Ufnal","year":"2019","unstructured":"Ufnal M, Nowi\u0144ski A. Is increased plasma TMAO a compensatory response to hydrostatic and osmotic stress in cardiovascular diseases? Med Hypotheses. 2019;130:109271. https:\/\/doi.org\/10.1016\/j.mehy.2019.109271.","journal-title":"Med Hypotheses"},{"key":"679_CR64","doi-asserted-by":"publisher","first-page":"e0189310","DOI":"10.1371\/journal.pone.0189310","volume":"12","author":"K Jaworska","year":"2017","unstructured":"Jaworska K, Huc T, Samborowska E, Dobrowolski L, Bielinska K, Gawlak M, Ufnal M. Hypertension in rats is associated with an increased permeability of the colon to TMA, a gut bacteria metabolite. PLoS ONE. 2017;12:e0189310. https:\/\/doi.org\/10.1371\/journal.pone.0189310.","journal-title":"PLoS ONE"},{"key":"679_CR65","doi-asserted-by":"publisher","first-page":"1075641","DOI":"10.3389\/fphys.2023.1075641","volume":"14","author":"KH Mutengo","year":"2023","unstructured":"Mutengo KH, Masenga SK, Mweemba A, Mutale W, Kirabo A. Gut microbiota dependant trimethylamine N-oxide and hypertension. Front Physiol. 2023;14:1075641. https:\/\/doi.org\/10.3389\/fphys.2023.1075641.","journal-title":"Front Physiol"},{"key":"679_CR66","doi-asserted-by":"publisher","first-page":"116567","DOI":"10.1016\/j.biopha.2024.116567","volume":"174","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Lv T, Wang X, Wu M, Zhang R, Yang X, Fu Y, Liu Z. Role of the microbiota-gut-heart axis between bile acids and cardiovascular disease. Biomed Pharmacother Biomedecine Pharmacother. 2024;174:116567. https:\/\/doi.org\/10.1016\/j.biopha.2024.116567.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"679_CR67","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00281-024-01012-x","volume":"46","author":"S Kim","year":"2024","unstructured":"Kim S, Seo S-U, Kweon M-N. Gut microbiota-derived metabolites tune host homeostasis fate. Semin Immunopathol. 2024;46:2. https:\/\/doi.org\/10.1007\/s00281-024-01012-x.","journal-title":"Semin Immunopathol"},{"key":"679_CR68","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1194\/jlr.R088989","volume":"60","author":"A Kriaa","year":"2019","unstructured":"Kriaa A, Bourgin M, Potiron A, Mkaouar H, Jablaoui A, G\u00e9rard P, Maguin E, Rhimi M. Microbial impact on cholesterol and bile acid metabolism: current status and future prospects. J Lipid Res. 2019;60:323\u201332. https:\/\/doi.org\/10.1194\/jlr.R088989.","journal-title":"J Lipid Res"},{"key":"679_CR69","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/liv.13394","volume":"37","author":"A Voiosu","year":"2017","unstructured":"Voiosu A, Wiese S, Voiosu T, Bendtsen F, M\u00f8ller S. Bile acids and cardiovascular function in cirrhosis. Liver Int Off J Int Assoc Study Liver. 2017;37:1420\u201330. https:\/\/doi.org\/10.1111\/liv.13394.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"679_CR70","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.3390\/molecules27113401","volume":"27","author":"Y Shulpekova","year":"2022","unstructured":"Shulpekova Y, Zharkova M, Tkachenko P, Tikhonov I, Stepanov A, Synitsyna A, Izotov A, Butkova T, Shulpekova N, Lapina N, et al. The role of bile acids in the human body and in the development of diseases. Molecules. 2022;27:3401. https:\/\/doi.org\/10.3390\/molecules27113401.","journal-title":"Molecules"},{"key":"679_CR71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.toxlet.2016.11.013","volume":"265","author":"A Carazo","year":"2017","unstructured":"Carazo A, Hyrsova L, Dusek J, Chodounska H, Horvatova A, Berka K, Bazgier V, Gan-Schreier H, Chamulitrat W, Kudova E, et al. Acetylated deoxycholic (DCA) and cholic (CA) acids are potent ligands of pregnane X (PXR) receptor. Toxicol Lett. 2017;265:86\u201396. https:\/\/doi.org\/10.1016\/j.toxlet.2016.11.013.","journal-title":"Toxicol Lett"},{"key":"679_CR72","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cardfail.2017.06.007","volume":"23","author":"CCK Mayerhofer","year":"2017","unstructured":"Mayerhofer CCK, Ueland T, Broch K, Vincent RP, Cross GF, Dahl CP, Aukrust P, Gullestad L, Hov JR, Tr\u00f8seid M. Increased secondary\/Primary bile acid ratio in chronic heart failure. J Card Fail. 2017;23:666\u201371. https:\/\/doi.org\/10.1016\/j.cardfail.2017.06.007.","journal-title":"J Card Fail"},{"key":"679_CR73","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.cardfail.2015.09.017","volume":"21","author":"Y Nagatomo","year":"2015","unstructured":"Nagatomo Y, Wilson Tang WH. Intersections between microbiome and heart failure: Revisiting the gut hypothesis. J Card Fail. 2015;21:973\u201380. https:\/\/doi.org\/10.1016\/j.cardfail.2015.09.017.","journal-title":"J Card Fail"},{"key":"679_CR74","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jchf.2015.10.009","volume":"4","author":"E Pasini","year":"2016","unstructured":"Pasini E, Aquilani R, Testa C, Baiardi P, Angioletti S, Boschi F, Verri M, Dioguardi F. Pathogenic gut flora in patients with chronic heart failure. JACC Heart Fail. 2016;4:220\u20137. https:\/\/doi.org\/10.1016\/j.jchf.2015.10.009.","journal-title":"JACC Heart Fail"},{"key":"679_CR75","doi-asserted-by":"publisher","first-page":"378","DOI":"10.20524\/aog.2021.0596","volume":"34","author":"W Wongtrakul","year":"2021","unstructured":"Wongtrakul W, Charoenngnam N, Ungprasert P. The correlation between heart failure and the risk of ischemic colitis: a systematic review and meta-analysis. Ann Gastroenterol. 2021;34:378\u201384. https:\/\/doi.org\/10.20524\/aog.2021.0596.","journal-title":"Ann Gastroenterol"},{"key":"679_CR76","doi-asserted-by":"publisher","unstructured":"Sandek A, Swidsinski A, Schroedl W, Watson A, Valentova M, Herrmann R, Scherbakov N, Cramer L, Rauchhaus M, Grosse -Herrenthey Anke, et al. Intestinal Blood Flow in Patients With Chronic Heart Failure. JACC. 2014;64:1092\u20131102. https:\/\/doi.org\/10.1016\/j.jacc.2014.06.1179","DOI":"10.1016\/j.jacc.2014.06.1179"},{"key":"679_CR77","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/microorganisms10030578","volume":"10","author":"T Hrncir","year":"2022","unstructured":"Hrncir T. Gut microbiota dysbiosis: Triggers, consequences diagnostic and therapeutic options. Microorganisms. 2022;10:578. https:\/\/doi.org\/10.3390\/microorganisms10030578.","journal-title":"Microorganisms"},{"key":"679_CR78","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.3390\/ijms23073698","volume":"23","author":"J Maiuolo","year":"2022","unstructured":"Maiuolo J, Carresi C, Gliozzi M, Mollace R, Scarano F, Scicchitano M, Macr\u00ec R, Nucera S, Bosco F, Oppedisano F, et al. The contribution of gut microbiota and endothelial dysfunction in the development of arterial hypertension in animal models and in humans. Int J Mol Sci. 2022;23:3698. https:\/\/doi.org\/10.3390\/ijms23073698.","journal-title":"Int J Mol Sci"},{"key":"679_CR79","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1002\/ehf2.14009","volume":"9","author":"N Li","year":"2022","unstructured":"Li N, Zhou J, Wang Y, Chen R, Li J, Zhao X, Zhou P, Liu C, Song L, Liao Z, et al. Association between trimethylamine N-oxide and prognosis of patients with acute myocardial infarction and heart failure. ESC Heart Fail. 2022;9:3846\u201357. https:\/\/doi.org\/10.1002\/ehf2.14009.","journal-title":"ESC Heart Fail"},{"key":"679_CR80","doi-asserted-by":"publisher","first-page":"1334730","DOI":"10.3389\/fcvm.2024.1334730","volume":"11","author":"X Li","year":"2024","unstructured":"Li X, Wang Y, Xu J, Luo K, Dong T. Association between trimethylamine N-oxide and prognosis of patients with myocardial infarction: a meta-analysis. Front Cardiovasc Med. 2024;11:1334730. https:\/\/doi.org\/10.3389\/fcvm.2024.1334730.","journal-title":"Front Cardiovasc Med"},{"key":"679_CR81","doi-asserted-by":"publisher","first-page":"117031","DOI":"10.1016\/j.biopha.2024.117031","volume":"177","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Y, Jin S, Lv J, Li M, Feng N. The gut microbiota derived metabolite trimethylamine N-oxide: Its important role in cancer and other diseases. Biomed Pharmacother Biomedecine Pharmacother. 2024;177:117031. https:\/\/doi.org\/10.1016\/j.biopha.2024.117031.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"679_CR82","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.3390\/microorganisms10122382","volume":"10","author":"RMRA Effendi","year":"2022","unstructured":"Effendi RMRA, Anshory M, Kalim H, Dwiyana RF, Suwarsa O, Pardo LM, Nijsten TEC, Thio HB. Akkermansia muciniphila and faecalibacterium prausnitzii in immune-related diseases. Microorganisms. 2022;10:2382. https:\/\/doi.org\/10.3390\/microorganisms10122382.","journal-title":"Microorganisms"},{"key":"679_CR83","doi-asserted-by":"publisher","first-page":"16643","DOI":"10.1038\/srep16643","volume":"5","author":"M Schneeberger","year":"2015","unstructured":"Schneeberger M, Everard A, G\u00f3mez-Valad\u00e9s AG, Matamoros S, Ram\u00edrez S, Delzenne NM, Gomis R, Claret M, Cani PD. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep. 2015;5:16643. https:\/\/doi.org\/10.1038\/srep16643.","journal-title":"Sci Rep"},{"key":"679_CR84","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.21037\/atm-22-5671","volume":"10","author":"X Qian","year":"2022","unstructured":"Qian X, Liu A, Liang C, He L, Xu Z, Tang S. Analysis of gut microbiota in patients with acute myocardial infarction by 16S rRNA sequencing. Ann Transl Med. 2022;10:1340. https:\/\/doi.org\/10.21037\/atm-22-5671.","journal-title":"Ann Transl Med"},{"key":"679_CR85","doi-asserted-by":"publisher","unstructured":"Zuo J, Wang P, Xue K, Tan Y, Zhang T, Li Y, He F, Wu W, Yan Z, Cong L, et al. Lipid alterations in acute myocardial infarction are associated with gut microbiota. Microbiol Spectr. 2025;0:e02370\u201324. https:\/\/doi.org\/10.1128\/spectrum.02370-24.","DOI":"10.1128\/spectrum.02370-24"},{"key":"679_CR86","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40168-018-0441-4","volume":"6","author":"X Zhou","year":"2018","unstructured":"Zhou X, Li J, Guo J, Geng B, Ji W, Zhao Q, Li J, Liu X, Liu J, Guo Z, et al. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome. 2018;6:66. https:\/\/doi.org\/10.1186\/s40168-018-0441-4.","journal-title":"Microbiome"},{"key":"679_CR87","doi-asserted-by":"publisher","first-page":"16517","DOI":"10.1038\/s41598-022-20826-z","volume":"12","author":"M-A Gagn\u00e9","year":"2022","unstructured":"Gagn\u00e9 M-A, Barbeau C, Fr\u00e9geau G, Gilbert K, Mathieu O, Auger J, Tompkins TA, Charbonney E, Godbout R, Rousseau G. Dysbiotic microbiota contributes to the extent of acute myocardial infarction in rats. Sci Rep. 2022;12:16517. https:\/\/doi.org\/10.1038\/s41598-022-20826-z.","journal-title":"Sci Rep"},{"key":"679_CR88","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.118.035235","volume":"139","author":"TWH Tang","year":"2019","unstructured":"Tang TWH, Chen H-C, Chen C-Y, Yen CYT, Lin C-J, Prajnamitra RP, Chen L-L, Ruan S-C, Lin J-H, Lin P-J, et al. Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair. Circulation. 2019;139:647\u201359. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035235.","journal-title":"Circulation"},{"key":"679_CR89","doi-asserted-by":"publisher","first-page":"G342","DOI":"10.1152\/ajpgi.00018.2019","volume":"317","author":"RM Lataro","year":"2019","unstructured":"Lataro RM, Imori PFM, Santos ES, Silva LEV, Duarte RTD, Silva CAA, Falc\u00e3o JP, Paton JFR, Salgado HC. Heart failure developed after myocardial infarction does not affect gut microbiota composition in the rat. Am J Physiol-Gastrointest Liver Physiol. 2019;317:G342\u20138. https:\/\/doi.org\/10.1152\/ajpgi.00018.2019.","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"679_CR90","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s12275-024-00164-7","volume":"62","author":"L Li","year":"2024","unstructured":"Li L, Sun J-Y, Li Y-L, Zhu S-W, Duan S-Z. The gut microbiota mediates the protective effects of spironolactone on myocardial infarction. J Microbiol. 2024;62:883\u201395. https:\/\/doi.org\/10.1007\/s12275-024-00164-7.","journal-title":"J Microbiol"},{"key":"679_CR91","doi-asserted-by":"publisher","first-page":"e011797","DOI":"10.1161\/JAHA.118.011797","volume":"8","author":"J Amar","year":"2019","unstructured":"Amar J, Lelouvier B, Servant F, Lluch J, Burcelin R, Bongard V, Elbaz M. Blood microbiota modification after myocardial infarction depends upon low-density lipoprotein cholesterol levels. J Am Heart Assoc. 2019;8:e011797. https:\/\/doi.org\/10.1161\/JAHA.118.011797.","journal-title":"J Am Heart Assoc"},{"key":"679_CR92","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3390\/jcm11051462","volume":"11","author":"F-C Chiu","year":"2022","unstructured":"Chiu F-C, Tsai C-F, Huang P-S, Shih C-Y, Tsai M-H, Hwang J-J, Wang Y-C, Chuang EY, Tsai C-T, Chang S-N. The gut microbiome, seleno-compounds, and acute myocardial infarction. J Clin Med. 2022;11:1462. https:\/\/doi.org\/10.3390\/jcm11051462.","journal-title":"J Clin Med"},{"key":"679_CR93","doi-asserted-by":"publisher","unstructured":"Fan Y, Ying J, Huangfu N, He K, Hu T, Su P, Hu X, He H, Liang W, Liu J, et al. Multiomics reveals gut dysbiosis contributes to fatty acid dysmetabolism in early phase of acute myocardial infarction. eLife. 2024;13: https:\/\/doi.org\/10.7554\/eLife.98868.1.","DOI":"10.7554\/eLife.98868.1"},{"key":"679_CR94","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1096\/fj.11-197921","volume":"26","author":"V Lam","year":"2012","unstructured":"Lam V, Su J, Koprowski S, Hsu A, Tweddell JS, Rafiee P, Gross GJ, Salzman NH, Baker JE. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 2012;26:1727\u201335. https:\/\/doi.org\/10.1096\/fj.11-197921.","journal-title":"FASEB J"},{"key":"679_CR95","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1559827618812395","volume":"13","author":"JM Rippe","year":"2018","unstructured":"Rippe JM. Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease. Am J Lifestyle Med. 2018;13:204\u201312. https:\/\/doi.org\/10.1177\/1559827618812395.","journal-title":"Am J Lifestyle Med"},{"key":"679_CR96","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/VHRM.S379874","volume":"19","author":"A Diab","year":"2023","unstructured":"Diab A, Dastmalchi LN, Gulati M, Michos ED. A heart-healthy diet for cardiovascular disease prevention: Where are we now? Vasc Health Risk Manag. 2023;19:237\u201353. https:\/\/doi.org\/10.2147\/VHRM.S379874.","journal-title":"Vasc Health Risk Manag"},{"key":"679_CR97","doi-asserted-by":"publisher","unstructured":"Ghanbari F, Hasani S, Aghili ZS, Asgary S. The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: A review. https:\/\/doi.org\/10.1002\/fsn3.4142","DOI":"10.1002\/fsn3.4142"},{"key":"679_CR98","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.3390\/nu15173686","volume":"15","author":"M Romero","year":"2023","unstructured":"Romero M, Duarte J. Probiotics and prebiotics in cardiovascular diseases. Nutrients. 2023;15:3686. https:\/\/doi.org\/10.3390\/nu15173686.","journal-title":"Nutrients"},{"key":"679_CR99","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/nu16040570","volume":"16","author":"A Pant","year":"2024","unstructured":"Pant A, Chew DP, Mamas MA, Zaman S. Cardiovascular disease and the Mediterranean diet: Insights into sex-specific responses. Nutrients. 2024;16:570. https:\/\/doi.org\/10.3390\/nu16040570.","journal-title":"Nutrients"},{"key":"679_CR100","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00394-002-0370-6","volume":"41","author":"MA Mart\u00ednez-Gonz\u00e1lez","year":"2002","unstructured":"Mart\u00ednez-Gonz\u00e1lez MA, Fern\u00e1ndez-Jarne E, Serrano-Mart\u00ednez M, Marti A, Martinez JA, Mart\u00edn-Moreno JM. Mediterranean diet and reduction in the risk of a first acute myocardial infarction: an operational healthy dietary score. Eur J Nutr. 2002;41:153\u201360. https:\/\/doi.org\/10.1007\/s00394-002-0370-6.","journal-title":"Eur J Nutr"},{"key":"679_CR101","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.3390\/nu15122749","volume":"15","author":"VJ Clemente-Su\u00e1rez","year":"2023","unstructured":"Clemente-Su\u00e1rez VJ, Beltr\u00e1n-Velasco AI, Redondo-Fl\u00f3rez L, Mart\u00edn-Rodr\u00edguez A, Tornero-Aguilera JF. Global impacts of western diet and its effects on metabolism and health: A narrative review. Nutrients. 2023;15:2749. https:\/\/doi.org\/10.3390\/nu15122749.","journal-title":"Nutrients"},{"key":"679_CR102","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1001\/jamainternmed.2013.9768","volume":"173","author":"S Li","year":"2013","unstructured":"Li S, Chiuve SE, Flint A, Pai JK, Forman JP, Hu FB, Willett WC, Mukamal KJ, Rimm EB. Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med. 2013;173:1808\u201319. https:\/\/doi.org\/10.1001\/jamainternmed.2013.9768.","journal-title":"JAMA Intern Med"},{"key":"679_CR103","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1080\/10408398.2018.1564019","volume":"60","author":"K Zhang","year":"2020","unstructured":"Zhang K, Chen X, Zhang L, Deng Z. Fermented dairy foods intake and risk of cardiovascular diseases: A meta-analysis of cohort studies. Crit Rev Food Sci Nutr. 2020;60:1189\u201394. https:\/\/doi.org\/10.1080\/10408398.2018.1564019.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"679_CR104","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.3390\/nu13082878","volume":"13","author":"H Wu","year":"2021","unstructured":"Wu H, Chiou J. Potential benefits of probiotics and prebiotics for coronary heart disease and stroke. Nutrients. 2021;13:2878. https:\/\/doi.org\/10.3390\/nu13082878.","journal-title":"Nutrients"},{"key":"679_CR105","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1002\/mco2.420","volume":"4","author":"J Ji","year":"2023","unstructured":"Ji J, Jin W, Liu S, Jiao Z, Li X. Probiotics, prebiotics, and postbiotics in health and disease. MedComm. 2023;4:e420. https:\/\/doi.org\/10.1002\/mco2.420.","journal-title":"MedComm"},{"key":"679_CR106","doi-asserted-by":"publisher","unstructured":"Mansuy-Aubert V, Ravussin Y. Short chain fatty acids: the messengers from down below. Front Neurosci. 2023;17: https:\/\/doi.org\/10.3389\/fnins.2023.1197759.","DOI":"10.3389\/fnins.2023.1197759"},{"key":"679_CR107","doi-asserted-by":"publisher","first-page":"g2659","DOI":"10.1136\/bmj.g2659","volume":"348","author":"S Li","year":"2014","unstructured":"Li S, Flint A, Pai JK, Forman JP, Hu FB, Willett WC, Rexrode KM, Mukamal KJ, Rimm EB. Dietary fiber intake and mortality among survivors of myocardial infarction: prospective cohort study. The BMJ. 2014;348:g2659. https:\/\/doi.org\/10.1136\/bmj.g2659.","journal-title":"The BMJ"},{"key":"679_CR108","doi-asserted-by":"publisher","unstructured":"Dong W, Yang Z. Association of dietary fiber intake with myocardial infarction and stroke events in US Adults: A cross-sectional study of NHANES 2011\u20132018. Front Nutr. 2022;9: https:\/\/doi.org\/10.3389\/fnut.2022.936926","DOI":"10.3389\/fnut.2022.936926"},{"key":"679_CR109","doi-asserted-by":"publisher","first-page":"6761","DOI":"10.3390\/ijms23126761","volume":"23","author":"Z Guan","year":"2022","unstructured":"Guan Z, Feng Q. Chitosan and chitooligosaccharide: The promising non-plant-derived prebiotics with multiple biological activities. Int J Mol Sci. 2022;23:6761. https:\/\/doi.org\/10.3390\/ijms23126761.","journal-title":"Int J Mol Sci"},{"key":"679_CR110","doi-asserted-by":"publisher","unstructured":"Wang Y, Liu S, Tang D, Dong R, Feng Q. Chitosan oligosaccharide ameliorates metabolic syndrome induced by overnutrition via altering intestinal microbiota. Front Nutr. 2021;8: https:\/\/doi.org\/10.3389\/fnut.2021.743492.","DOI":"10.3389\/fnut.2021.743492"},{"key":"679_CR111","doi-asserted-by":"publisher","first-page":"7658052","DOI":"10.1155\/2019\/7658052","volume":"2019","author":"T Jiang","year":"2019","unstructured":"Jiang T, Xing X, Zhang L, Liu Z, Zhao J, Liu X. Chitosan oligosaccharides show protective effects in coronary heart disease by improving antioxidant capacity via the increase in intestinal probiotics. Oxid Med Cell Longev. 2019;2019:7658052. https:\/\/doi.org\/10.1155\/2019\/7658052.","journal-title":"Oxid Med Cell Longev"},{"key":"679_CR112","doi-asserted-by":"publisher","first-page":"1487641","DOI":"10.3389\/fmicb.2024.1487641","volume":"15","author":"B Sarita","year":"2024","unstructured":"Sarita B, Samadhan D, Hassan MZ, Kovaleva EG. A comprehensive review of probiotics and human health-current prospective and applications. Front Microbiol. 2024;15:1487641. https:\/\/doi.org\/10.3389\/fmicb.2024.1487641.","journal-title":"Front Microbiol"},{"key":"679_CR113","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/microorganisms12030430","volume":"12","author":"ME Abouelela","year":"2024","unstructured":"Abouelela ME, Helmy YA. Next-generation probiotics as novel therapeutics for improving human health: Current trends and future perspectives. Microorganisms. 2024;12:430. https:\/\/doi.org\/10.3390\/microorganisms12030430.","journal-title":"Microorganisms"},{"key":"679_CR114","doi-asserted-by":"publisher","unstructured":"Sarita B, Samadhan D, Hassan MZ, Kovaleva EG. A comprehensive review of probiotics and human health-current prospective and applications. Front Microbiol. 2025;15: https:\/\/doi.org\/10.3389\/fmicb.2024.1487641.","DOI":"10.3389\/fmicb.2024.1487641"},{"key":"679_CR115","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/jpm14020217","volume":"14","author":"M Kamel","year":"2024","unstructured":"Kamel M, Aleya S, Alsubih M, Aleya L. Microbiome dynamics: A paradigm shift in combatting infectious diseases. J Pers Med. 2024;14:217. https:\/\/doi.org\/10.3390\/jpm14020217.","journal-title":"J Pers Med"},{"key":"679_CR116","doi-asserted-by":"publisher","first-page":"112409","DOI":"10.1016\/j.exger.2024.112409","volume":"189","author":"M Bijla","year":"2024","unstructured":"Bijla M, Saini SK, Pathak AK, Bharadwaj KP, Sukhavasi K, Patil A, Saini D, Yadav R, Singh S, Leeuwenburgh C, et al. Microbiome interactions with different risk factors in development of myocardial infarction. Exp Gerontol. 2024;189:112409. https:\/\/doi.org\/10.1016\/j.exger.2024.112409.","journal-title":"Exp Gerontol"},{"key":"679_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, Wu Z-X, Chen X-Y, Wang J-Q, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7:1\u201328. https:\/\/doi.org\/10.1038\/s41392-022-00974-4.","journal-title":"Signal Transduct Target Ther"},{"key":"679_CR118","doi-asserted-by":"publisher","unstructured":"Borshchev YuYu, Sonin DL, Burovenko IYu, Borshchev VYu, Cheburkin YuV, Borshcheva OV, Galagudza MM. The effect of probiotic strains on myocardial infarction size, biochemical and immunological parameters in rats with systemic inflammatory response syndrome and polymorbidity. J Evol Biochem Physiol. 2022;58:2058\u20132069. https:\/\/doi.org\/10.1134\/S0022093022060321.","DOI":"10.1134\/S0022093022060321"},{"key":"679_CR119","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3389\/fmicb.2017.01687","volume":"8","author":"Z Liu","year":"2017","unstructured":"Liu Z, Liu H-Y, Zhou H, Zhan Q, Lai W, Zeng Q, Ren H, Xu D. Moderate-intensity exercise affects gut microbiome composition and influences cardiac function in myocardial infarction mice. Front Microbiol. 2017;8:1687. https:\/\/doi.org\/10.3389\/fmicb.2017.01687.","journal-title":"Front Microbiol"},{"key":"679_CR120","doi-asserted-by":"publisher","unstructured":"Gan XT, Ettinger G, Huang CX, Burton JP, Haist JV, Rajapurohitam V, Sidaway JE, Martin G, Gloor GB, Swann JR, et al. Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ Heart Fail. 2014.https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000978.","DOI":"10.1161\/CIRCHEARTFAILURE.113.000978"},{"key":"679_CR121","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12265-020-10052-1","volume":"14","author":"J Moludi","year":"2021","unstructured":"Moludi J, Saiedi S, Ebrahimi B, Alizadeh M, Khajebishak Y, Ghadimi SS. Probiotics supplementation on cardiac remodeling following myocardial infarction: a single-center double-blind clinical study. J Cardiovasc Transl Res. 2021;14:299\u2013307. https:\/\/doi.org\/10.1007\/s12265-020-10052-1.","journal-title":"J Cardiovasc Transl Res"},{"key":"679_CR122","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1097\/PSY.0000000000000749","volume":"81","author":"J Moludi","year":"2019","unstructured":"Moludi J, Alizadeh M, Mohammadzad MHS, Davari M. The Effect of probiotic supplementation on depressive symptoms and quality of life in patients after myocardial infarction: Results of a preliminary double-blind clinical trial. Biopsychosoc Sci Med. 2019;81:770. https:\/\/doi.org\/10.1097\/PSY.0000000000000749.","journal-title":"Biopsychosoc Sci Med"},{"key":"679_CR123","doi-asserted-by":"publisher","unstructured":"Sefidgari-Abrasi S, Roshangar L, Karimi P, Morshedi M, Rahimiyan-Heravan M, Saghafi-Asl M. From the gut to the heart: L. plantarum and inulin administration as a novel approach to control cardiac apoptosis via 5-HT2B and TrkB receptors in diabetes. Clin Nutr Edinb Scotl. 2021;40:190\u2013201. https:\/\/doi.org\/10.1016\/j.clnu.2020.05.004.","DOI":"10.1016\/j.clnu.2020.05.004"},{"key":"679_CR124","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3389\/fmicb.2020.01400","volume":"11","author":"I Spacova","year":"2020","unstructured":"Spacova I, Dodiya HB, Happel A-U, Strain C, Vandenheuvel D, Wang X, Reid G. Future of probiotics and prebiotics and the implications for early career researchers. Front Microbiol. 2020;11:1400. https:\/\/doi.org\/10.3389\/fmicb.2020.01400.","journal-title":"Front Microbiol"},{"key":"679_CR125","doi-asserted-by":"publisher","unstructured":"Wu J, Singleton SS, Bhuiyan U, Krammer L, Mazumder R. Multi-omics approaches to studying gastrointestinal microbiome in the context of precision medicine and machine learning. Front Mol Biosci. 2024;10: https:\/\/doi.org\/10.3389\/fmolb.2023.1337373.","DOI":"10.3389\/fmolb.2023.1337373"},{"key":"679_CR126","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10916-024-02089-5","volume":"48","author":"JMP de la Lastra","year":"2024","unstructured":"de la Lastra JMP, Wardell SJT, Pal T, de la Fuente-Nunez C, Pletzer D. From data to decisions: Leveraging artificial intelligence and machine learning in combating antimicrobial resistance \u2013 a comprehensive review. J Med Syst. 2024;48:71. https:\/\/doi.org\/10.1007\/s10916-024-02089-5.","journal-title":"J Med Syst"},{"key":"679_CR127","doi-asserted-by":"publisher","first-page":"2185034","DOI":"10.1080\/19490976.2023.2185034","volume":"15","author":"D Merenstein","year":"2023","unstructured":"Merenstein D, Pot B, Leyer G, Ouwehand AC, Preidis GA, Elkins CA, Hill C, Lewis ZT, Shane AL, Zmora N, et al. Emerging issues in probiotic safety: 2023 perspectives. Gut Microbes. 2023;15:2185034. https:\/\/doi.org\/10.1080\/19490976.2023.2185034.","journal-title":"Gut Microbes"},{"key":"679_CR128","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13063-023-07443-5","volume":"24","author":"Y Chen","year":"2023","unstructured":"Chen Y, Chen R, Wang X, Zhou Y, Hong L, Xiong N, Zhu J, Ye S, Tan X. Effect of probiotic supplementation on in-hospital mortality in patients with acute myocardial infarction: a study protocol for an open-label, randomized, controlled, superiority clinical trial. Trials. 2023;24:429. https:\/\/doi.org\/10.1186\/s13063-023-07443-5.","journal-title":"Trials"},{"key":"679_CR129","doi-asserted-by":"publisher","first-page":"e35980","DOI":"10.1016\/j.heliyon.2024.e35980","volume":"10","author":"T Jan","year":"2024","unstructured":"Jan T, Negi R, Sharma B, Kumar S, Singh S, Rai AK, Shreaz S, Rustagi S, Chaudhary N, Kaur T, et al. Next generation probiotics for human health: An emerging perspective. Heliyon. 2024;10:e35980. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35980.","journal-title":"Heliyon"},{"key":"679_CR130","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/fbe2.12081","volume":"3","author":"AK Meher","year":"2024","unstructured":"Meher AK, Acharya B, Sahu PK. Probiotics: Bridging the interplay of a healthy gut and psychoneurological well-being. Food Bioeng. 2024;3:126\u201347. https:\/\/doi.org\/10.1002\/fbe2.12081.","journal-title":"Food Bioeng"}],"container-title":["Current Nutrition Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-025-00679-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13668-025-00679-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-025-00679-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T07:00:32Z","timestamp":1751094032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13668-025-00679-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1007\/s13668-025-00679-4","relation":{},"ISSN":["2161-3311"],"issn-type":[{"value":"2161-3311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"16 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with humans or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"88"}}